<DOC>
	<DOCNO>NCT01094444</DOCNO>
	<brief_summary>The study aim explore benefit topical vitamin K3 lotion reactivation/rephosphorylation EGF-receptor skin possible reduction cutaneous side effect EGFr-inhibition . Primary aim : The possible reduction cutaneous side effect : folliculitis , dryness redness skin . Secondary aim : To explore possible side effect topical vitamin K3 lotion . Methods : 36 patient metastatic colorectal cancer metastatic head neck cancer allocate treatment chemotherapy biweekly cetuximab . Two equally sized area least 10x10 cm back chest patient mark . Patients receive double blind procedure placebo lotion one side vitamin K3 lotion side . The treatment may last maximum two month patient follow biweekly photo , VAS-scores , questionnaire CTCAE estimation . The patient able take weekly photo home week see outpatient clinic . During treatment skin product antibiotic allow carefully register health care professional outpatient clinic . The patient may enter trial two different way : 18 patient start treatment study lotion time start treatment cetuximab . The 18 patient start treatment study lotion folliculitis appear . Patients ask 1.5 mm skin biopsy study area skin start treatment 4 week treatment placebo lotion vitamin K3 lotion . These biopsy investigate EGFr , phosphorylated EGFr central downstream mechanism . The biopsy part study optional patient .</brief_summary>
	<brief_title>Investigation Effect Vitamin K3-lotion Treatment Cetuximab Induced Folliculitis</brief_title>
	<detailed_description />
	<mesh_term>Folliculitis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 3</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Planned ongoing treatment cetuximab Age least 18 year Informed write consent accord local national legislation Known disease influence either treatment , evaluation outcome current disease treatment , include chronic dermatology Known hypersensitivity menadion Concomitant treatment Vitamin K Vitamin Kantagonists Known psychological , family , sociological geographic condition potentially influence plan study treatment followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Vitamin K3 lotion</keyword>
	<keyword>Cetuximab induce folliculitis</keyword>
</DOC>